Millipore Sigma Vibrant Logo

259545 Deoxyhypusine Synthase Inhibitor, GC7 - CAS 150333-69-0 - Calbiochem

The Deoxyhypusine Synthase Inhibitor, GC7, also referenced under CAS 150333-69-0, controls the biological activity of Deoxyhypusine Synthase.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: 1-(7-ammonioheptyl)guanidinium sulfate, N1-guanyl-1,7-diamine-heptane

View Products on Sigmaaldrich.com
259545
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
150333-69-0C₈H₂₂N₄O₄S

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
259545-10MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Glasflasche 10 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA cell-permeable inhibitor that targets the spermidine-binding site of Deoxyhypusine Synthase (Ki = 9.7 nM), an enzyme which is responsible for the first step hypunisation of eukaryotic initiation factor 5A (eIF5A). In vivo, it demonstrates almost complete cessation of hypusine formation in CHO cells at ≥ 1 µM. Several studies indicate this compound as a useful tool for the down-regulation of eIF5A, a protein essential for cell proliferation. For example, it exhibits an anti-proliferative effect on both BCR-ABL -positive and -negative leukemia cell lines (K562 and HL-60) dose-dependently, at concentrations between 5 µM and 40 µM. In addition, it is shown to significantly impair the growth and invasion of primary HCC cells (HepG2 and Hep3B) in the 10-20 µM range, and against non-tumorigenic CL-48 cells at concentrations as high as 40 µM, with no apparent cytotoxicity. At 25 µM, GC7 treatment is shown to reverse eIF5a-mediated Skeletal Muscle Stem Cell Differentiation.
      Catalogue Number259545
      Brand Family Calbiochem®
      Synonyms1-(7-ammonioheptyl)guanidinium sulfate, N1-guanyl-1,7-diamine-heptane
      References
      ReferencesLee, N.P., et al. 2010. Int J Cancer. 4, 968.
      Luchessi, A., et al. 2008. J Cell Physiol. 3, 480.
      Balabanov, S., et al. 2007. Blood. 4, 1701.
      Jakus, J., et al. 1993. J Biol Chem. 18, 13151.
      Product Information
      CAS number150333-69-0
      FormWhite powder
      Hill FormulaC₈H₂₂N₄O₄S
      Chemical formulaC₈H₂₂N₄O₄S
      Hygroscopic Hygroscopic
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity>95% by NMR
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      259545-10MG 04055977217421

      Documentation

      Deoxyhypusine Synthase Inhibitor, GC7 - CAS 150333-69-0 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Deoxyhypusine Synthase Inhibitor, GC7 - CAS 150333-69-0 - Calbiochem Analysenzertifikate

      TitelChargennummer
      259545

      Literatur

      Übersicht
      Lee, N.P., et al. 2010. Int J Cancer. 4, 968.
      Luchessi, A., et al. 2008. J Cell Physiol. 3, 480.
      Balabanov, S., et al. 2007. Blood. 4, 1701.
      Jakus, J., et al. 1993. J Biol Chem. 18, 13151.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision14-May-2012 JSW
      Synonyms1-(7-ammonioheptyl)guanidinium sulfate, N1-guanyl-1,7-diamine-heptane
      DescriptionA cell-permeable inhibitor that targets the spermidine-binding site of Deoxyhypusine Synthase (Ki = 9.7 nM), an enzyme which is responsible for the first step hypunisation of eukaryotic initiation factor 5A (eIF5A). In vivo, it demonstrates almost complete cessation of hypusine formation in CHO cells at ≥ 1 µM. Several studies indicate this compound as a useful tool for the down-regulation of eIF5A, a protein essential for cell proliferation. For example, it exhibits an anti-proliferative effect on both BCR-ABL -positive and -negative leukemia cell lines (K562 and HL-60) dose-dependently, at concentrations between 5 µM and 40 µM. In addition, it is shown to significantly impair the growth and invasion of primary HCC cells (HepG2 and Hep3B) in the 10-20 µM range, and against non-tumorigenic CL-48 cells at concentrations as high as 40 µM, with no apparent cytotoxicity. At 25 µM, GC7 treatment is shown to reverse eIF5a-mediated Skeletal Muscle Stem Cell Differentiation.
      FormWhite powder
      CAS number150333-69-0
      Chemical formulaC₈H₂₂N₄O₄S
      Structure formulaStructure formula
      Purity>95% by NMR
      SolubilityH₂O (25 mg/ml; clear, colorless solution)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesLee, N.P., et al. 2010. Int J Cancer. 4, 968.
      Luchessi, A., et al. 2008. J Cell Physiol. 3, 480.
      Balabanov, S., et al. 2007. Blood. 4, 1701.
      Jakus, J., et al. 1993. J Biol Chem. 18, 13151.